Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune toleranceFrancesca De Filippis, Roberto Berni Canani, Lorella Paparo et al.|Nature Communications|2021Cited by 202
The therapeutic efficacy of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> BB‐12<sup>®</sup> in infant colic: A randomised, double blind, placebo‐controlled trialRita Nocerino, Roberto Berni Canani, Antonio Marino et al.|Alimentary Pharmacology & Therapeutics|2019Cited by 90
Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infectionLorella Paparo, Roberto Berni Canani|Scientific Reports|2020Cited by 78
Therapeutic effects elicited by the probiotic <i>Lacticaseibacillus</i> <i>rhamnosus</i> GG in children with atopic dermatitis. The results of the ProPAD trialLaura R. Carucci, Roberto Berni Canani, Rita Nocerino et al.|Pediatric Allergy and Immunology|2022Cited by 65
The Impact of Formula Choice for the Management of Pediatric Cow’s Milk Allergy on the Occurrence of Other Allergic Manifestations: The Atopic March Cohort StudyRita Nocerino, Roberto Berni Canani, Giorgio Bedogni et al.|The Journal of Pediatrics|2021Cited by 53